Novel psychoactive substances: Use and knowledge among adolescents and young adults in urban and rural areas

Human Psychopharmacology

Volumn 30, Issue 4, 2015, Pages 295-301

  Martinotti, Giovanni ^a   Lupi, Matteo ^a   Carlucci, Leonardo ^a   Cinosi, Eduardo ^a   Santacroce, Rita ^a   Acciavatti, Tiziano ^a   Chillemi, Eleonora ^b   Bonifaci, Ludovica ^b   Janiri, Luigi ^c   Di Giannantonio, Massimo ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b LUMSA UNIVERSITY   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

Author keywords

addiction; adolescents; novel psychoactive substances; young adults

Indexed keywords

4' METHYLMETHCATHINONE; CANNABINOID; CANNABIS; DESOMORPHINE; METHAMPHETAMINE; MORPHINE DERIVATIVE; PHENETHYLAMINE DERIVATIVE; PSYCHOTROPIC AGENT; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ALCOHOL CONSUMPTION; ALCOHOLIC BEVERAGE; ARTICLE; BINGE DRINKING; CONTROLLED STUDY; DRUG MISUSE; ENERGY DRINK; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH BEHAVIOR; HUMAN; ITALY; KNOWLEDGE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RURAL AREA; SALVIA DIVINORUM; SMOKING; URBAN AREA; YOUNG ADULT; PSYCHOLOGY; QUESTIONNAIRE; RURAL POPULATION; STATISTICS AND NUMERICAL DATA; SUBSTANCE-RELATED DISORDERS; URBAN POPULATION;

ADOLESCENT; ADULT; FEMALE; HUMANS; KNOWLEDGE; MALE; PSYCHOTROPIC DRUGS; RURAL POPULATION; SUBSTANCE-RELATED DISORDERS; SURVEYS AND QUESTIONNAIRES; URBAN POPULATION; YOUNG ADULT;

EID: 84938056356     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.2486     Document Type: Article

References (32)

1. Ansa Abruzzo. 2014. http://www.ansa.it/abruzzo/notizie/2014/07/15/raffineria-droga-zombie-a-pescara-7a5253dd-57ec-425c bac6-fbcf7fae9c6d.html.
2. Bersani FS, Corazza O, Albano G, et al,. 2014. 25C-NBOMe: preliminary data on pharmacology, psychoactive effects, and toxicity of a new potent and dangerous hallucinogenic drug. Biomed Res Int 2014: 734749.
3. Biliński P, Kapka-Skrzypczak L, Jabłoński P,. 2012. Determining the scale of designer drugs (DD) abuse and risk to public health in Poland through an epidemiological study in adolescents. Ann Agric Environ Med 19 (3): 357-364.
4. Brandt SD, Sumnall HR, Measham F, Cole J,. 2010. Analyses of second-generation 'legal highs' in the UK: initial findings. Drug Test Anal 2 (8): 377-382.
5. Bruno R, Matthews AJ, Dunn M, et al,. 2012. Emerging psychoactive substance use among regular ecstasy users in Australia. Drug Alcohol Depend 124 (1-2): 19-25.
6. Cinosi E, Corazza O, Santacroce R, et al,. 2014. New drugs on the Internet: the case of Camfetamine. Biomed Res Int 2014: 419026.
7. Corazza O, Assi S, Simonato P, et al,. 2013. Promoting innovation and excellence to face the rapid diffusion of Novel Psychoactive Substances in the EU: the outcomes of the ReDNet project. Hum Psychopharmacol 28 (4): 317-323.
8. Corazza O, Simonato P, Corkery JM, et al,. 2014. Legal highs: safe and legal heavens? A study on the diffusion, knowledge and risk awareness of novel psychoactive drugs among students in the UK. Riv Psichiatr 49 (2): 89-94.
9. Currie CL,. 2013. Epidemiology of adolescent Salvia divinorum use in Canada. Drug Alcohol Depend 128 (1-2): 166-170.
10. Davey Z, Schifano F, Corazza O, Deluca P,. 2012. Psychonaut Web Mapping Group. e-Psychonauts: conducting research in online drug forum communities. J Ment Health 21 (4): 386-394.
11. European Commission. 2011. Youth attitudes on drugs, Flash Eurobarometer 330, http://ec.europa.eu/public-opinion/flash/fl-330-en.pdf.
12. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). March 2015. New Psychoactive Substances in Europe. An Update from the EU Early Warning System. EMCDDA: Lisbon.
13. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). November 2012. Annual report on the state of the drugs problem in Europe. EMCDDA: Lisbon.
14. Forrester MB,. 2012. Adolescent synthetic cannabinoid exposures reported to Texas Poison Centers. Pediatr Emerg Care 28 (10): 985-999.
15. Goodman LA,. 1961. Snowball sampling. Annals Math Stat 32: 148-170.
16. Harpham T,. 1994. Urbanization and mental health in developing countries: a research role for social scientists, public health professionals and social psychiatrists. Soc Sci Med 39: 233-245.
17. Hatzigiakoumis DS, Martinotti G, Giannantonio MD, Janiri L,. 2011. Anhedonia and substance dependence: clinical correlates and treatment options. Front Psychiatry 2: 10.
18. Kelly BC, Wells BE, Pawson M, Leclair A, Parsons JT, Golub SA,. 2013. Novel psychoactive drug use among younger adults involved in US nightlife scenes. Drug Alcohol Rev 32 (6): 588-593.
19. Kline P,. 2000. The Handbook of Psychometric Testing, 2nd edn. Routledge: London, UK.
20. Koetsenruijter J, van Lieshout J, Vassilev I, et al,. 2014. Social support systems as determinants of self-management and quality of life of people with diabetes across Europe: study protocol for an observational study. Health Qual Life Outcomes 12 (1): 29.
21. Martinotti G, Carli V, Tedeschi D, et al,. 2009. Mono- and polysubstance dependent subjects differ on social factors, childhood trauma, personality, suicidal behaviour, and comorbid Axis I diagnoses. Addict Behav 34 (9): 790-793.
22. Martinotti G, Lupi M, Acciavatti T, et al,. 2014. Novel psychoactive substances in young adults with and without psychiatric comorbidities. Biomed Res Int 2014: 815424.
23. Mathurin P, Deltenre P,. 2009. Effect of binge drinking on the liver: an alarming public health issue? Gut 58 (5): 613-617.
24. McAuley A, Hecht G, Barnsdale L, et al,. 2014. Mortality related to novel psychoactive substances in Scotland: an exploratory study. 2012. Int J Drug Policy 26 (5): 461-467.
25. Mongerstern C, Werse B,. 2012. Proceedings of the 1st International Conference on Toxicity, Risk Profiles, Legal Control and Prevalence of Synthetic Cannabinoids, Conference Handout-Conference on SPICE Prevention Issues, http:// www.uniklinik-freiburg.de/rechtsmedizin/live/SpiceConference/ ConferenceHandout.pdf.
26. Schifano F, Deluca P, Agosti L, et al,. 2005. New trends in the cyber and street market of recreational drugs? The case of 2C-T-7 ('Blue Mystic'). J Psychopharmacol 19 (6): 675-679.
27. Schifano F, Albanese A, Fergus S, et al,. 2011. Mephedrone (4-methylmethcathinone; 'meow meow'): chemical, pharmacological and clinical issues. Psychopharmacology (Berl) 214 (3): 593-602.
28. Schifano F, Orsolini L, Papanti D, Corkery J,. 2015. Novel psychoactive substances of interest for psychiatry. World Psychiatry 14: 15-26.
29. United Nations Office on Drugs and Crime. 2014. World Drug Report (United Nations publication, Sales No. E.14.XI.7).
30. Vanyukov MM, Tarter RE, Kirillova GP, et al,. 2012. Common liability to addiction and 'gateway hypothesis': theoretical, empirical and evolutionary perspective. Drug Alcohol Depend 123 (Suppl 1): S3-S17.
31. Vento AE, Martinotti G, Cinosi E, et al,. 2014. Substance use in the club scene of Rome: a pilot study. Biomed Res Int 2014: 617546.
32. Wechsler H, Nelson TF,. 2001. Binge drinking and the American college student: what's five drinks? Psychol Addict Behav 15: 287-291.